The technology allows for mammalian transfection-ready DNA constructs to be synthesized, assembled into custom vectors, and amplified in a single day on the BioXp™ Gene Builder, eliminating the need to clone and copy DNA in E. coli. SAN DIEGO--SGI-DNA announces the launch of Gibson Assembly® RapidAMP™ technology—a novel approach that allows for cell-free synthesis and amplification of [...]

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system Professor Maria Andreasen from Aarhus University and Aaron Venables, Product Director from Fluidic Analytics cut the ribbon on the Fluidity One-W at PEGS 2019 CAMBRIDGE, UK – Fluidic Analytics Ltd, experts in protein analysis and the company behind in-solution diffusional sizing, launches a breakthrough innovation [...]

HTG EdgeSeq Reveal software version 2.0.0 streamlines data analysis process and enhances user experience TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday announced the release of its HTG EdgeSeq Reveal data analysis software, version 2.0.0. HTG EdgeSeq Reveal is a powerful software [...]

DENVILLE, NJ and HERCULES, Calif. – Diagenode, Inc., a leading global provider of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital [...]

BIRMINGHAM, Ala. TriAltus Bioscience, LLC today announced the launch of its Activated Im7 affinity chromatography resin for the CL7/Im7 protein purification system. This new version more than doubles the single-step protein purification system’s original binding capacity from 15 – 20 mg/ml to 35 – 40 mg/ml of CL7-tagged protein. Proprietary chemical modifications to the Activated Im7 Resin enable it to [...]

Uniqsis has recently installed a 4-channel FlowSyn™ flow chemistry system in the Riley Research Group Laboratories at the University of Pretoria (South Africa).The Riley Research Group (www.rileygroup.co.za) is well known for its development of novel pharmaceuticals using flow synthesis, reaction engineering and the development of new chemical reactors. Currently the Riley group medicinal chemistry team is focusing on lead discovery [...]

PORTLAND, Ore. -- Northwest Analytics’ board of directors announced that Peter Guilfoyle has been appointed chief executive officer, president and director. Robert Ward, former CEO, will assume an advisory role. These changes were effective November 12, 2019. Guilfoyle was the Vice President of Marketing for Northwest Analytics. In that role, Guilfoyle drove the company to [...]

Collaboration between drug companies and contract research partners drives innovation in evolving business environment. Columbus, Ohio – CAS, a division of the American Chemical Society, announced today that leading contract research, development and manufacturing organization (CRO/CDMO) BioDuro has signed a five-year agreement for SciFindern. This agreement provides enterprise-wide access to the most advanced scientific information solution [...]

Major Uruguay biotech distributor sees global potential for their country's cannabis crop BEVERLY, Mass. -- Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety and transparency of cannabis, today announced its partnership with Tagaca SRL as its distributor of record in Uruguay. Tagaca is the leading biotechnology distribution firm in Uruguay [...]

QIAGEN receives several conditional, non-binding indications of interest, and decides to enter into discussions to explore potential strategic alternatives Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) announces it has begun a review of potential strategic alternatives after receiving several conditional, non-binding indications of interest for the acquisition of [...]